[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Europe Biosurgery Market 2020-2027 by Product, Source Type (Natural, Synthetic), Application (Orthopedic, General, Neurological, Cardiovascular), and Country: Trend Outlook and Growth Opportunity

June 2021 | 104 pages | ID: E54BE56F6B1BEN
GMD Research

US$ 2,210.00 US$ 2,600.00 -15 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Europe biosurgery market accounted for $3,610.6 million in 2020 and will grow by 6.2% annually over 2020-2027 owing to the growth in joint reconstruction and spinal fusion, the increasing number of surgeries especially minimally invasive surgeries due to lifestyle disorders and the rise in the overweight & aging population.

Highlighted with 34 tables and 50 figures, this 104-page report “Europe Biosurgery Market 2020-2027 by Product, Source Type (Natural, Synthetic), Application (Orthopedic, General, Neurological, Cardiovascular), and Country: Trend Outlook and Growth Opportunity” is based on a comprehensive research of the entire Europe biosurgery market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2027 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
  • Market Structure
  • Growth Drivers
  • Restraints and Challenges
  • Emerging Product Trends & Market Opportunities
  • Porter’s Fiver Forces
The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Europe biosurgery market in every aspect of the classification from perspectives of Product, Source Type, Application, and Country.

Based on Product, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2017-2027 included in each section.
  • Hemostatic Agents
  • Bone-graft Substitutes
    • Synthetic Graft Extender
    • Demineralized Bone Matrix
    • Bone Morphogenetic Proteins
    • Cell-Based Matrices
  • Surgical Sealants and Adhesives
    • Natural Surgical Sealing Agents
    • Synthetic Surgical Sealing Agents
  • Soft-tissue Attachments
    • Natural & Biological Mesh/Patch
    • Synthetic Mesh/Patch
  • Adhesion Barriers
    • Natural Adhesion Barriers
    • Synthetic Adhesion Barriers
  • Staple Line Reinforcement
Based on Source Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2017-2027 included in each section.
  • Natural/Biological Products
  • Synthetic Products
Based on Application, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2017-2027 included in each section.
  • Orthopedic Surgery
  • General Surgery
  • Neurological Surgery
  • Cardiovascular Surgery
  • Gynecological Surgery
  • Other Applications
Geographically, the following national/local markets are fully investigated:
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Russia
  • Rest of Europe (further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2017-2027. The breakdown of key national markets by Product, Source Type, and Application over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Key Players (this may not be a complete list and extra companies can be added upon request):
B. Braun Melsungen AG
Baxter International, Inc.
Becton, Dickinson and Company (C.R. Bard)
Betatech Medical
CryoLife Inc.
CSL Limited
Hemostasis LLC
Integra Lifesciences Holdings Corporation
Johnson & Johnson
Medtronic PLC
Pfizer, Inc.
Sanofi S.A.

Stryker Corporation
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 INTRODUCTION

1.1 Industry Definition and Research Scope
  1.1.1 Industry Definition
  1.1.2 Research Scope
1.2 Research Methodology
  1.2.1 Overview of Market Research Methodology
  1.2.2 Market Assumption
  1.2.3 Secondary Data
  1.2.4 Primary Data
  1.2.5 Data Filtration and Model Design
  1.2.6 Market Size/Share Estimation
  1.2.7 Research Limitations
1.3 Executive Summary

2 MARKET OVERVIEW AND DYNAMICS

2.1 Market Size and Forecast
  2.1.1 Impact of COVID-19 on World Economy
  2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis

3 SEGMENTATION OF EUROPE MARKET BY PRODUCT

3.1 Market Overview by Product
3.2 Hemostatic Agents
3.3 Bone-graft Substitutes
  3.2.1 Synthetic Graft Extender
  3.2.2 Demineralized Bone Matrix
  3.2.3 Bone Morphogenetic Proteins
  3.2.4 Cell-Based Matrices
3.4 Surgical Sealants and Adhesives
  3.4.1 Natural Surgical Sealing Agents
  3.4.2 Synthetic Surgical Sealing Agents
3.5 Soft-tissue Attachments
  3.5.1 Natural & Biological Mesh/Patch
  3.5.2 Synthetic Mesh/Patch
3.6 Adhesion Barriers
  3.6.1 Natural Adhesion Barriers
  3.6.2 Synthetic Adhesion Barriers
3.7 Staple Line Reinforcement

4 SEGMENTATION OF EUROPE MARKET BY SOURCE TYPE

4.1 Market Overview by Source Type
4.2 Natural/Biological Products
4.3 Synthetic Products

5 SEGMENTATION OF EUROPE MARKET BY APPLICATION

5.1 Market Overview by Application
5.2 Orthopedic Surgery
5.3 General Surgery
5.4 Neurological Surgery
5.5 Cardiovascular Surgery
5.6 Gynecological Surgery
5.7 Other Applications

6 EUROPEAN MARKET 2020-2027 BY COUNTRY

6.1 Overview of European Market
6.2 UK
6.3 France
6.4 Germany
6.5 Spain
6.6 Italy
6.7 Russia
6.8 Rest of European Market

7 COMPETITIVE LANDSCAPE

7.1 Overview of Key Vendors
7.2 New Product Launch, Partnership, Investment, and M&A
7.3 Company Profiles
B. Braun Melsungen AG
Baxter International, Inc.
Becton, Dickinson and Company (C.R. Bard)
Betatech Medical
CryoLife Inc.
CSL Limited
Hemostasis LLC
Integra Lifesciences Holdings Corporation
Johnson & Johnson
Medtronic PLC
Pfizer, Inc.
Sanofi S.A.
Stryker Corporation
RELATED REPORTS

LIST OF TABLES

Table 1. Snapshot of Europe Biosurgery Market in Balanced Perspective, 2020-2027
Table 2. Growth Rate of World GDP, 2020-2022
Table 3. Main Product Trends and Market Opportunities in Europe Biosurgery Market
Table 4. Europe Biosurgery Market by Product, 2017-2027, $ mn
Table 5. Europe Biosurgery Market: Bone-Graft Substitutes by Type, 2017-2027, $ mn
Table 6. Europe Biosurgery Market: Surgical Sealants and Adhesives by Type, 2017-2027, $ mn
Table 7. Europe Biosurgery Market: Soft-tissue Attachments by Type, 2017-2027, $ mn
Table 8. Europe Biosurgery Market: Adhesion Barriers by Type, 2017-2027, $ mn
Table 9. Europe Biosurgery Market by Source Type, 2017-2027, $ mn
Table 10. Europe Biosurgery Market by Application, 2017-2027, $ mn
Table 11. Europe Biosurgery Market by Country, 2017-2027, $ mn
Table 12. UK Biosurgery Market by Product, 2017-2027, $ mn
Table 13. UK Biosurgery Market by Source Type, 2017-2027, $ mn
Table 14. UK Biosurgery Market by Application, 2017-2027, $ mn
Table 15. France Biosurgery Market by Product, 2017-2027, $ mn
Table 16. France Biosurgery Market by Source Type, 2017-2027, $ mn
Table 17. France Biosurgery Market by Application, 2017-2027, $ mn
Table 18. Germany Biosurgery Market by Product, 2017-2027, $ mn
Table 19. Germany Biosurgery Market by Source Type, 2017-2027, $ mn
Table 20. Germany Biosurgery Market by Application, 2017-2027, $ mn
Table 21. Spain Biosurgery Market by Product, 2017-2027, $ mn
Table 22. Spain Biosurgery Market by Source Type, 2017-2027, $ mn
Table 23. Spain Biosurgery Market by Application, 2017-2027, $ mn
Table 24. Italy Biosurgery Market by Product, 2017-2027, $ mn
Table 25. Italy Biosurgery Market by Source Type, 2017-2027, $ mn
Table 26. Italy Biosurgery Market by Application, 2017-2027, $ mn
Table 27. Russia Biosurgery Market by Product, 2017-2027, $ mn
Table 28. Russia Biosurgery Market by Source Type, 2017-2027, $ mn
Table 29. Russia Biosurgery Market by Application, 2017-2027, $ mn
Table 30. Biosurgery Market in Rest of Europe by Country, 2017-2027, $ mn
Table 31. B. Braun Melsungen AG: Company Snapshot
Table 32. B. Braun Melsungen AG: Business Segmentation
Table 33. B. Braun Melsungen AG: Product Portfolio
Table 34. B. Braun Melsungen AG: Revenue, 2017-2019, $ mn

LIST OF FIGURES

Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2020-2027
Figure 4. Europe Biosurgery Market, 2017-2027, $ mn
Figure 5. Impact of COVID-19 on Business
Figure 6. Primary Drivers and Impact Factors of Europe Biosurgery Market
Figure 7. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million
Figure 8. Primary Restraints and Impact Factors of Europe Biosurgery Market
Figure 9. Investment Opportunity Analysis
Figure 10. Porter’s Fiver Forces Analysis of Europe Biosurgery Market
Figure 11. Breakdown of Europe Biosurgery Market by Product, 2020-2027, % of Revenue
Figure 12. Contribution to Europe 2021-2027 Cumulative Revenue by Product, Value ($ mn) and Share (%)
Figure 13. Europe Biosurgery Market: Hemostatic Agents, 2017-2027, $ mn
Figure 14. Europe Biosurgery Market: Bone-graft Substitutes, 2017-2027, $ mn
Figure 15. Europe Biosurgery Market: Synthetic Graft Extender, 2017-2027, $ mn
Figure 16. Europe Biosurgery Market: Demineralized Bone Matrix, 2017-2027, $ mn
Figure 17. Europe Biosurgery Market: Bone Morphogenetic Proteins, 2017-2027, $ mn
Figure 18. Europe Biosurgery Market: Cell-Based Matrices, 2017-2027, $ mn
Figure 19. Europe Biosurgery Market: Surgical Sealants and Adhesives, 2017-2027, $ mn
Figure 20. Europe Biosurgery Market: Natural Surgical Sealing Agents, 2017-2027, $ mn
Figure 21. Europe Biosurgery Market: Synthetic Surgical Sealing Agents, 2017-2027, $ mn
Figure 22. Europe Biosurgery Market: Soft-tissue Attachments, 2017-2027, $ mn
Figure 23. Europe Biosurgery Market: Natural & Biological Mesh/Patch, 2017-2027, $ mn
Figure 24. Europe Biosurgery Market: Synthetic Mesh/Patch, 2017-2027, $ mn
Figure 25. Europe Biosurgery Market: Adhesion Barriers, 2017-2027, $ mn
Figure 26. Europe Biosurgery Market: Natural Adhesion Barriers, 2017-2027, $ mn
Figure 27. Europe Biosurgery Market: Synthetic Adhesion Barriers, 2017-2027, $ mn
Figure 28. Europe Biosurgery Market: Staple Line Reinforcement, 2017-2027, $ mn
Figure 29. Breakdown of Europe Biosurgery Market by Source Type, 2020-2027, % of Revenue
Figure 30. Contribution to Europe 2021-2027 Cumulative Revenue by Source Type, Value ($ mn) and Share (%)
Figure 31. Europe Biosurgery Market: Natural/Biological Products, 2017-2027, $ mn
Figure 32. Europe Biosurgery Market: Synthetic Products, 2017-2027, $ mn
Figure 33. Breakdown of Europe Biosurgery Market by Application, 2020-2027, % of Revenue
Figure 34. Contribution to Europe 2021-2027 Cumulative Revenue by Application, Value ($ mn) and Share (%)
Figure 35. Europe Biosurgery Market: Orthopedic Surgery, 2017-2027, $ mn
Figure 36. Europe Biosurgery Market: General Surgery, 2017-2027, $ mn
Figure 37. Europe Biosurgery Market: Neurological Surgery, 2017-2027, $ mn
Figure 38. Europe Biosurgery Market: Cardiovascular Surgery, 2017-2027, $ mn
Figure 39. Europe Biosurgery Market: Gynecological Surgery, 2017-2027, $ mn
Figure 40. Europe Biosurgery Market: Other Applications, 2017-2027, $ mn
Figure 41. Breakdown of European Biosurgery Market by Country, 2020 and 2027, % of Revenue
Figure 42. Contribution to Europe 2021-2027 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 43. Biosurgery Market in UK, 2017-2027, $ mn
Figure 44. Biosurgery Market in France, 2017-2027, $ mn
Figure 45. Biosurgery Market in Germany, 2017-2027, $ mn
Figure 46. Biosurgery Market in Spain, 2017-2027, $ mn
Figure 47. Biosurgery Market in Italy, 2017-2027, $ mn
Figure 48. Biosurgery Market in Russia, 2017-2027, $ mn
Figure 49. Biosurgery Market in Rest of Europe, 2017-2027, $ mn
Figure 50. Growth Stage of Europe Biosurgery Industry over the Forecast Period


More Publications